VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up

Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric P. Winer, Jonas Bergh, R.D. Gelber, Eleonora Restuccia, Y-H Im, Chao‐Yuan Huang, Florence Dalenc, Isabel Calvo, Marion Procter, C. Caballero, Emma Clark, Henry Gómez, Judith M. Bliss, Giovanna Viale, José Bines, Martine Piccart